Evommune (EVMN) Other Non Operating Income (2024 - 2026)
Evommune (EVMN) posted quarterly Other Non Operating Income of $2.3 million for Q1 2026, up 380.0% year-over-year from $475000.0 in Q1 2025, and down 75.82% quarter-over-quarter from $9.4 million in Q4 2025.
Evommune (EVMN) Other Non Operating Income (2024 - 2026) Analysis & Trends
Evommune (EVMN) has reported Other Non Operating Income for 3 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 380.0% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $13.0 million (changed N/A YoY), while the FY2025 annual figure was $12.2 million, up 280.69% from the prior year.
- Other Non Operating Income declined to $2.3 million in Q1 2026 per EVMN's latest filing, from $9.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $9.4 million in Q4 2025 and bottomed at $475000.0 in Q1 2025.
- Historically, Other Non Operating Income has averaged $2.4 million across 3 years, with a median of $790500.0 in 2024.
- On a YoY basis, Other Non Operating Income climbed as much as 1195.33% in 2025 and fell as far as 41.93% in 2025.
- Evommune's Other Non Operating Income stood at $728000.0 in 2024, then surged by 1195.33% to $9.4 million in 2025, then slumped by 75.82% to $2.3 million in 2026.
- Business Quant data shows EVMN's Other Non Operating Income at $2.3 million in Q1 2026, $9.4 million in Q4 2025, and $853000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Evommune | 531.53 Mn | 330.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.65 Mn |
| Mar 31, 2026 | 2.28 Mn |
| Dec 31, 2025 | 9.43 Mn |
| Sep 30, 2025 | 853,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Dec 31, 2024 | 728,000.00 |
| Sep 30, 2024 | 601,000.00 |